A new nanomaterial developed by scientists at the University of Bath could solve a conundrum faced by scientists probing some of the most promising types of future pharmaceuticals (Nanoscale Horizons, “Measuring optical activity in the far-field from a racemic nanomaterial: diffraction spectroscopy from plasmonic nanogratings”).
Scientists who study the nanoscale – with molecules and materials 10,000 smaller than a pinhead – need to be able to test the way that some molecules twist, known as their chirality, because mirror image molecules with the same structure can have very different properties. For instance one kind of molecule smells of lemons when it twists in one direction, and oranges when twisted the other way.
Detecting these twists is especially important in some high-value industries such as pharmaceuticals, perfumes, food additives and pesticides.
Recently, a new class of nanoscale materials have been developed to help distinguish the chirality of molecules. These so-called ‘nanomaterials’ usually consist of tiny twisted metal wires, that are chiral themselves.
However, it has become very hard to distinguish the twist of the nanomaterials from the twist of the molecules they are supposed to help study.
To solve this problem the team from the University of Bath’s Department of Physics created a nanomaterial that is both twisted and it is not. This nanomaterial has equal number of opposite twists – meaning they cancel each other out. Usually, upon interacting with light, such material appears without any twist; how then could it be optimised to interact with molecules?
Image Credit: Ventsislav Valev and Alex Murphy
News This Week
Coronavirus hits the old and those with other health problems hardest, but fit, youthful people are dying too, and experts are trying to understand why: It remains one of the biggest puzzles of the [...]
he past few weeks have revealed the worst and the best in human responses to the coronavirus crisis – from the supermarket hoarders clearing the shelves to the neighbourhood groups organising help for elderly [...]
An Oxford-based firm that uses artificial intelligence to develop new medicines has teamed up with a UK national science facility to screen more than 15,000 drugs for their effectiveness as a treatment for Covid-19. [...]
New research has shed light on a crucial biological mechanism that may have helped the coronavirus to infect humans and spread rapidly around the world. A detailed analysis of the virus’s structure shows that [...]
How does the COVID-19 pandemic compare to other infamous viral infections that have plagued us in modern times? It’s a question that’s been asked repeatedly in social media circles in recent weeks as people [...]
There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. Since the outbreak began in late 2019, researchers have been racing to [...]
Corona Virus (COVID 19) Interview with Michael Osterholm an expert in infectious disease epidemiology.
Michael Osterholm is an internationally recognized expert in infectious disease epidemiology. He is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the director of the Center for Infectious Disease Research and Policy [...]
With the new coronavirus spreading from person to person (possibly including from people without symptoms), reaching four continents, and traveling faster than SARS, driving it out of existence is looking increasingly unlikely. It’s still [...]
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have improved upon the 3D bioprinting technique they developed to engineer skeletal muscle as a potential therapy for replacing diseased or damaged muscle tissue, moving another [...]
An international team of scientists from the University of Southampton, the University of Padova, and the University of Zurich has connected a silicon neuron to a neuron from the rat hippocampus with an artificial [...]
In an insightful 42-minute interview, NMIN’s Scientific Director Dr. Pieter Cullis, a pioneer in liposomal gene and drug delivery, discusses his scientific career with a focus on his contributions to the evolution of [...]
A powerful antibiotic that kills some of the most dangerous drug-resistant bacteria in the world has been discovered using artificial intelligence. The drug works in a different way to existing antibacterials and is the [...]
Artificial intelligence hit a big milestone in January — the first drug designed entirely using artificial intelligence entered human clinical trials. The compound, created by Oxford-based biotech company Exscientia, is aimed at treating obsessive-compulsive [...]
Researchers at the Massachusetts General Hospital (MGH) in the US have uncovered the ‘Achilles’ heel’ of most viruses which plague mankind, and could soon develop a universal vaccine. Vaccine research, development and testing takes [...]
Every age in the history of human civilisation has a signature material, from the Stone Age, to the Bronze and Iron Ages. We might even call today’s information-driven society the Silicon Age. Since the [...]